A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia
Clinical trial NCT01358734 · COMPLETED
Trial details
- NCT number
- NCT01358734
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-27
- Primary completion
- 2015-05-19
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.